FRA:YB3'
s FCF Margin % Range Over the Past 10 Years
Min: -24.57 Med: 5.58 Max: 24.44
Current: 8.88
During the past 13 years, the highest FCF Margin % of Shin Nippon Biomedical Laboratories was 24.44%. The lowest was -24.57%. And the median was 5.58%.
FRA:YB3's FCF Margin % is ranked better than 74.51% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845
vs FRA:YB3: 8.88
Shin Nippon Biomedical Laboratories FCF Margin % Related Terms
Shin Nippon Biomedical Laboratories FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:YB3 vs TMO, DHR, IDXX: FCF Margin % Comparison
For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shin Nippon Biomedical Laboratories FCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shin Nippon Biomedical Laboratories's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shin Nippon Biomedical Laboratories (FRA:YB3) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shin Nippon Biomedical Laboratories and its competitors. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #52 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 25.5%.
Is Shin Nippon Biomedical Laboratories' FCF Margin % too high?
Shin Nippon Biomedical Laboratories' current FCF Margin % is 0.00%. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #52 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #52 out of 204 companies for FCF Margin %. This puts Shin Nippon Biomedical Laboratories in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shin Nippon Biomedical Laboratories and its competitors. Shin Nippon Biomedical Laboratories's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (FRA:YB3) has a current FCF Margin % of 0.00%. The stock's GF Value™ is €9.47, compared to a current price of €6.00 — trading 36.6% below its estimated fair value. The current FCF Margin % is 0.00%. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (FRA:YB3), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shin Nippon Biomedical Laboratories (FRA:YB3) Overvalued in 2026?
Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued.
The current stock price of €6.00 is trading 36.6% below its estimated GF Value™ of €9.47.
Key valuation signals for FRA:YB3:
FCF Margin %: 0.00%
GF Value™: €9.47 vs. price of €6.00 (36.6% below fair value)
No single metric tells the full story. See the FRA:YB3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shin Nippon Biomedical Laboratories Business Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score
Get the complete analysis for FRA:YB3
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:YB3 has been successfully added to your 
